Genespire
PrivateLast Round
Series B
Sep 25, 2024
Total Funding Raised
$69.39M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Genespire is a biotechnology company that develops off-the-shelf gene therapies for pediatric patients affected by genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genespire Comparables
Compare Genespire with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iECURE | 81% | |
| Eli Lilly and Company | 78% | |
| Vivet Therapeutics | 77% |
Genespire Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 25, 2024 | ||||
| Series A | Apr 29, 2020 |
Genespire Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| XGEN Venture | Series B |
| Indaco Venture Partners SGR | Series B |
| CDP Venture Capital SGR | Series B |
| Sofinnova Partners | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 286% MoM, from 317 to 1.2K.
- Apr 4, 2026
Monthly visitors increased 54% MoM.
Genespire Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genespire's valuation, stock price, and market status.
Is Genespire a public or private company?
Genespire is a private company.
What is the current stock price of Genespire?
Genespire is a private company with no public stock price. No recent secondary market data is available.
How much is Genespire worth (valuation)?
Valuation information for Genespire is not publicly available.
Can I buy Genespire stock?
Genespire shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genespire's last funding round?
Genespire's most recent funding round was Series B on September 25, 2024.
Who are the main investors in Genespire?
Key investors in Genespire include XGEN Venture, CDP Venture Capital SGR, Sofinnova Partners.
Will Genespire IPO soon?
No public IPO plans have been announced for Genespire.
How can I track Genespire secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genespire's secondary market activity and sign up for updates.